SARAJEVO (Bosnia and Herzegovina), March 1 (SeeNews) – Bosnian drug maker Bosnalijek [SAJ:BSNLR] has increased its capital by 10 million marka ($5.4 million/5.1 million euro) via a new ordinary share issue to a predetermined buyer, the securities registry of Bosnia's Federation said.